In an article published in the latest Symposium Issue of the Journal of Law, Medicine & Ethics "Antimicrobial Resistance Must Be Included in the Pandemic Instrument to Ensure Future Global Pandemic Readiness", ReAct calls for securing equitable and sustainable access to effective antibiotics and other countermeasures to be a key consideration in the upcoming pandemic instrument.
With the ongoing process of the Intergovernmental Negotiating Body to negotiate a new instrument for pandemic prevention, preparedness, and response, this special issue of the Journal of Law, Medicine & Ethics explores the inclusion of antimicrobial resistance (AMR) within the Pandemic Instrument from three perspectives:
- through the lens of global AMR governance
- from the perspective of technical governance challenges and opportunities affecting the global ability to address antimicrobial resistance and future pandemics and
- from the perspective of pandemic instrument mechanisms for strengthening global AMR governance.
Each paper offers concrete recommendations with respect to the importance of including antimicrobial resistance within the scope of the pandemic instrument.
ReAct contribution in the Symposium Issue of the Journal of Law, Medicine & Ethics:
The ReAct article emphasizes the critical importance of equitable access to antibiotics as a fundamental element of pandemic preparedness and response. It highlights the disproportionate impact of the lack of access to effective antibiotics, with low- and middle-income countries being the most affected. To achieve equitable access, a health systems approach is required, including the strengthening of preventive measures, diagnostics, and infrastructure, as well as coordinated efforts towards health workforce and quality care. Additionally, reforming antibiotic innovation to ensure equitable and sustainable access is crucial.
The publication outlines the key components that must be coordinated to achieve sustainable access to effective antibiotics, which can form important building blocks in a pandemic instrument. This involves coordinated action and adequate financing to ensure antibiotic effectiveness as a global public good.
Policymakers should consider the following 4 key messages when developing a new global agreement
1. Antibiotic effectiveness is a global public good, and preserving it is a shared responsibility.
Governments must take globally coordinated action to ensure equitable and sustainable access for all those in need.
2. Prevention of infections is one of the most cost-effective measures for reducing the need for antibiotics and managing antibiotic resistance.
The pandemic instrument should include minimum standards and target setting for infection prevention and control (IPC) and water, sanitation, and hygiene (WASH), reinforced by global goals, including achieving quality health for all.
3. Pandemic preparedness depends on an effective, global, integrated surveillance system.
Policymakers should explore the use of low-cost environmental surveillance, such as a global wastewater surveillance system. The pandemic instrument should support increasing diagnostic capacity, laboratory infrastructure, educated personnel, and strengthening national surveillance systems in LMICs. Integrated analysis of data across the human, animal, and environment sectors that account for both viral and bacterial threats is crucial.
4. The pandemic instrument should introduce standards, procedures, and clear mechanisms for monitoring and accountability, along with adequate financing and resources for implementation.
Public leadership is needed to institutionalize global prioritization, coordination, and long-term funding of Research & Development activities. low- and-middle-income countries must be given adequate resources to follow up mandates and measures, and rules-based governance, including transparency of data, global sharing of knowledge and technology, and equitable allocation and distribution, must be established.
More from "2023"
- New ReAct Brief: Antibiotic resistance is one of the greatest & most urgent cross-border health crises of our time – but still not addressed as such!
- 3 questions to MSF: Antimicrobial resistance in the ongoing Gaza war
- ReAct reports from the first AMR Multi-stakeholder Partnership Platform Plenary Assembly
- Workshop on community engagement on antibiotic resistance
- ReAct Asia Pacific: Youth engagement in India
- ReAct highlights World AMR Awareness Week 2023
- Latin America Empowered Communities: One Health meeting with diverse and hopeful voices
- Zambia: March for treatable infections during World AMR Awareness Week
- Release ReAct Africa Conference Report
- ReAct activities for World AMR Awareness Week 2023
- Join React Latin America Empowered Communities Meeting Series in November!
- Join ReAct webinar! AMR High-level Meeting 2024: Mobilizing Collective Action
- ReAct Report: Unlocking Barriers for Collective Action
- 5 reasons why the European Transferable Exclusivity Voucher proposal should go in the bin
- Alforja Educativa launched in Brazil!
- ReAct Asia Pacific: Engaging youth on AMR
- Antibiotic smart students and Teachers
- Key takeaways from the ReAct Africa & South Centre Conference 2023
- ART, BACTERIA AND THE MICROBIOME – A book launch in Ecuador
- Community engagement series – education and advocacy materials!
- Student Kyembe Ignitius Salachi
- ReAct is hiring! Are you our new Director for ReAct Asia Pacific?
- Strengthening Diagnostics Capacity: How can the newly adopted resolution help to contain the spread of antibiotic resistance?
- Almedalen 2023
- Join international dialogue on Art, Microbes and Planetary Health!
- Key achievements on antibiotic resistance during the Swedish EU Council Presidency
- ReAct Africa Conference 2023
- 3 reason why a new Pandemic Accord should address antibiotic resistance
- ReAct’s Impact Report 2019-2022!
- Ambitious new AMR recommendations adopted by EU Member States today
- 33rd ECCMID – ReAct’s highlights and impressions
- Uppsala Dialogue meeting: Experts from more than 20 countries gathered for collaborative actions on ABR
- ReAct Asia Pacific: Sensitizing civil society in India
- Sweden: International high-level meeting – unlocking barriers for collective action on antibiotic resistance
- Sweden’s successful approach to antibiotic resistance can be used as inspiration in other countries
- When Doctor Rianto suffered from antibiotic resistance as a patient
- ReAct Latin America: Cycling as community engagement
- Statement by ReAct – in response to the EC adoption of the revised pharmaceutical legislation proposal
- Mitigating AMR using implementation research: a development funder’s approach
- High-level conference in Japan: Universal Health Coverage, pandemic prevention, preparedness & response and AMR in focus
- New UNEP report – spotlight on environment and AMR
- New publication! Equitable access to antibiotics: A core element for pandemic preparedness and response
- Sustainable access to effective antibiotics in focus at Swedish EU presidency High-level meeting
- New ReAct Expert Policy Brief: 5 key challenges and public not-for-profit solutions in early stages antibiotics R&D
- Time is ticking – more needs to be done to tackle antibiotic resistance
- Sweden: Towards an antibiotic smart society
- Lancet article: Transferable exclusivity voucher: A flawed incentive to stimulate antibiotic innovation
- Lancet article: An analysis of existing national action plans for antimicrobial resistance – gaps and opportunities in strategies optimising antibiotic use in human populations
- New experts in the ReAct Toolbox Advisory Group!
- Dancing with bacteria: a theatrical performance about antibiotic resistance
- Malin Grape – Sweden’s AMR Ambassador on her role and the Swedish EU Presidency
- Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance
- Dr. Jaya Ranjalkar new Director ReAct Asia Pacific